Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.36 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | TERT | O14746 | 7/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL40079 | 0.97 | CDC25A (0.45) | CDC25AHPGDALOX15PABPC1CTDSP1 | |
| Iodide SCHEMBL30297486 | 0.95 | CDC25A (0.44) | CDC25AHPGDALOX15PABPC1CTDSP1 | |
| Hydrochloric Acid SCHEMBL15361368 | 0.95 | CDC25A (0.44) | CDC25AHPGDALOX15PABPC1CTDSP1 | |
| Water SCHEMBL15361295 | 0.95 | CDC25A (0.44) | CDC25AHPGDALOX15PABPC1CTDSP1 | |
| SCHEMBL18575589 | 0.91 | CDC25A (0.41) | CDC25AHPGDALOX15PABPC1CTDSP1 | |
| SCHEMBL1719164 | 0.89 | CDC25A (0.41) | CDC25AHPGDALOX15PABPC1CTDSP1 | |
| Bromide SCHEMBL2347777 | 0.86 | CDC25A (0.49) | CDC25AHPGDALOX15PABPC1CTDSP1 | |
| Bromide SCHEMBL3781155 | 0.84 | CDC25A (0.51) | CDC25AHPGDALOX15PABPC1CTDSP1 | |
| SCHEMBL9935792 | 0.84 | HPGD (0.47) | CDC25AHPGDALOX15PABPC1CTDSP1 | |
| SCHEMBL1491002 | 0.83 | CDC25A (0.50) | CDC25AHPGDALOX15PABPC1CTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2089414-B1 | USE OF IONIC LIQUIDS FOR MEMBRANE PROTEIN EXTRACTION | MERCK PATENT GMBH (DE) | 2013-03-06 | — | — | EP | claimed |
| US-8143381-B2 | Use of ionic liquids for membrane protein extraction | MERCK PATENT GMBH (DE) | 2012-03-27 | — | — | US | claimed |
| US-20100029917-A1 | USE OF IONIC LIQUIDS FOR MEMBRANE PROTEIN EXTRACTION | MERCK PATENT GMBH (DE) | 2010-02-04 | — | — | US | claimed |
| EP-3170789-B1 | PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE AMMONIUM SALT | NIPPON SODA CO (JP) | 2018-04-18 | — | — | EP | disclosed |
| EP-3170789-A1 | PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE SALT | NIPPON SODA CO., LTD. (JP) | 2017-05-24 | — | — | EP | disclosed |
| US-9242862-B2 | Process for production of fluorosulfonylimide ammonium salt | NIPPON SODA CO., LTD. (JP) | 2016-01-26 | — | — | US | disclosed |
| US-9096502-B2 | Production process for fluorosulfonylimide ammonium salt | NIPPON SODA CO., LTD. (JP) | 2015-08-04 | — | — | US | disclosed |
| EP-2674395-A1 | PROCESS FOR PRODUCTION OF FLUOROSULFONYLIMIDE AMMONIUM SALT | Nippon Soda Co., Ltd. (JP) | 2013-12-18 | — | — | EP | disclosed |
| US-20130331609-A1 | PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE AMMONIUM SALT | NIPPON SODA CO., LTD. (JP) | 2013-12-12 | — | — | US | disclosed |
| US-20130323154-A1 | PROCESS FOR PRODUCTION OF FLUOROSULFONYLIMIDE AMMONIUM SALT | NIPPON SODA CO., LTD. (JP) | 2013-12-05 | — | — | US | disclosed |
| EP-2660196-A1 | MANUFACTURING METHOD FOR FLUOROSULFONYLIMIDE AMMONIUM SALT | Nippon Soda Co., Ltd. (JP) | 2013-11-06 | — | — | EP | disclosed |
| EP-2089414-B1 | USE OF IONIC LIQUIDS FOR MEMBRANE PROTEIN EXTRACTION | MERCK PATENT GMBH (DE) | 2013-03-06 | — | — | EP | disclosed |
| US-8143381-B2 | Use of ionic liquids for membrane protein extraction | MERCK PATENT GMBH (DE) | 2012-03-27 | — | — | US | disclosed |
| US-20100029917-A1 | USE OF IONIC LIQUIDS FOR MEMBRANE PROTEIN EXTRACTION | MERCK PATENT GMBH (DE) | 2010-02-04 | — | — | US | disclosed |
| EP-2089414-A1 | USE OF IONIC LIQUIDS FOR MEMBRANE PROTEIN EXTRACTION | Merck Patent GmbH (DE) | 2009-08-19 | — | — | EP | disclosed |
| WO-2008058604-A1 | USE OF IONIC LIQUIDS FOR MEMBRANE PROTEIN EXTRACTION | MERCK PATENT GMBH (DE) | 2008-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130331609-A1 | PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE AMMONIUM SALT | NPEPPS, DNPEP, FOS | CDC25A 2308/4885HPGD 3509/4885ALOX15 4632/4885 |
| US-20100029917-A1 | USE OF IONIC LIQUIDS FOR MEMBRANE PROTEIN EXTRACTION | APMAP, VAMP8, VAMP7 | CDC25A 4145/4885HPGD 4350/4885ALOX15 4529/4885 |
| US-20130323154-A1 | PROCESS FOR PRODUCTION OF FLUOROSULFONYLIMIDE AMMONIUM SALT | ASNS, NHERF1, NAAA | CDC25A 2879/4885HPGD 3142/4885ALOX15 4575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.